Brief: Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-The-Market Under Nasdaq Rules
Feb 10 (Reuters) - Cancer Genetics Inc CGIX.O :
* CANCER GENETICS ANNOUNCES $17.5 MILLION COMMON STOCK
OFFERING
PRICED AT-THE-MARKET UNDER NASDAQ RULES
* CANCER GENETICS INC - ISSUED 2,777,778 SHARES OF ITS
COMMON
STOCK AT A PURCHASE PRICE OF $6.30 PER SHARE
Source text for Eikon: ID:nGNX2GkYKg
Further company coverage: CGIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration